Immunomodulation of the allergic inflammatory response: New developments

Inflammation and Allergy - Drug Targets

Volumn 9, Issue 2, 2010, Pages 73-82

  Araujo, Maria I ^a,b,c   Campos, Regis A ^a   Cardoso, Luciana S ^a   Oliveira, Sérgio C ^d   Carvalho, Edgar M ^a,b,c  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^c The National Institute of Science and Technology in Tropical Diseases (INCT DT CNPq)   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Allergy; Asthma; Atopy; Immunoregulation

Indexed keywords

CYTOKINE; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 25; INTERLEUKIN 33; TRANSFORMING GROWTH FACTOR BETA; AUTACOID; IMMUNOLOGIC FACTOR;

ALLERGIC DISEASE; ALLERGIC REACTION; ARTICLE; ASTHMA; CD4+ CD25+ T LYMPHOCYTE; HELMINTHIASIS; HISTAMINE RELEASE; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; PATHOGENESIS; SCHISTOSOMIASIS; TH1 CELL; TH2 CELL; ANIMAL; GENETICS; HELMINTH; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; MOUSE; RHINITIS;

ANIMALS; ASTHMA; HELMINTHIASIS; HELMINTHS; HUMANS; HYPERSENSITIVITY; IMMUNOLOGIC FACTORS; IMMUNOMODULATION; INFLAMMATION MEDIATORS; MICE; RHINITIS; TH1 CELLS; TH2 CELLS;

EID: 77953752925     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152810791292836     Document Type: Article

References (124)

1. Sears, M.R. Descriptive epidemiology of asthma. Lancet, 1997. 350(Suppl 2), SII1-4.
2. Yazdanbakhsh, M.; Kremsner, P.G.; van Ree, R. Allergy, parasites, and the hygiene hypothesis. Science, 2002, 296, 490-494.
3. Romagnani, S. Atopic allergy and other hypersensitivities interactions between genetic susceptibility, innocuous and/or microbial antigens and the immune system. Curr. Opin. Immunol., 1997, 9, 773-775.
4. Foster, P.S.; Hogan, S.P.; Ramsay, A.J.; Matthaei, K.I.; Young, I.G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med., 1996, 183, 195-201.
5. Cheung, P.F.; Wong, C.K.; Ip, W.K.; Lam, CW. IL-25 regulates the expression of adhesion molecules on eosinophils: mechanism of eosinophilia in allergic inflammation. Allergy, 2006, 61, 878-885.
6. Kondo, Y.; Yoshimoto, T.; Yasuda, K.; Futatsugi-Yumikura, S.; Morimoto, M.; Hayashi, N.; Hoshino, T.; Fujimoto, J.; Nakanishi, K. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int. Immunol., 2008, 20, 791-800.
7. Nakajima, H.; Takatsu, K. Role of cytokines in allergic airway inflammation. Int. Arch. Allergy Immunol., 2007, 142, 265-273.
8. Cho, S.H.; Stanciu, L.A.; Holgate, S.T.; Johnston, S.L. Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma. Am. J. Respir. Crit. Care Med, 2005, 171, 224-230.
9. Smart, J.M.; Kemp, A.S. Increased Th1 and Th2 allergen-induced cytokine responses in children with atopic disease. Clin. Exp. Allergy, 2002, 32, 796-802.
10. Ballantyne, S.J.; Barlow, J.L.; Jolin, H.E.; Nath, P.; Williams, A.S.; Chung, K.F.; Sturton, G.; Wong, S.H.; McKenzie, A.N. Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J. Allergy Clin. Immunol., 2007, 120, 1324-1331.
11. Strachan, D.P. Hay fever, hygiene, and household size. BMJ, 1989, 299, 1259-1260.
12. Strachan, D.P. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax, 2000, 55(Suppl 1), S2-10.
13. Araujo, M.I.; Hoppe, B.; Medeiros, M. Jr.; Alcantara, L.; Almeida, M.C.; Schriefer, A.; Oliveira, R.R.; Kruschewsky, R.; Figueiredo, J.P.; Cruz, A.A.; Carvalho, E.M. Impaired T helper 2 response to aeroallergen in helminth-infected patients with asthma. J. Infect. Dis., 2004, 190, 1797-1803.
14. van den Biggelaar, A.H.; van Ree, R.; Rodrigues, L.C.; Lell, B.; Deelder, A.M.; Kremsner, P.G.; Yazdanbakhsh, M. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet, 2000, 356, 1723-1727.
15. Oliveira, R.R.; Gollob, K.J.; Figueiredo, J.P.; Alcântara, L.M.; Cardoso, L.S.; Aquino, C.S.; Campos, R.A.; Almeida, M.C.; Carvalho, E.M.; Araújo, M.I. Schistosoma mansoni infection alters co-stimulatory molecule expression and cell activation in asthma. Microbes. Infect., 2009, 11, 223-229.
16. Cardoso, L.S.; Oliveira, S.C.; Goes, A.M.; Oliveira, R.R.; Pacifico, L.G.; Marinho, F.V.; Fonseca, C.T.; Cardoso, F.C.; Carvalho, E.M.; Araújo, M.I. Schistosoma mansoni antigens modulate the allergic response in a murine model of ovalbumin-induced airway inflammation. Clin. Exp. Immunol., 2010, 99, 1-9.
17. Pacifico, L.G.; Marinho, F.A.; Fonseca, C.T.; Barsante, M.M.; Pinho, V.; Sales-Junior, P.A.; Cardoso, L.S.; Araújo, M.I.; Carvalho, E.M.; Cassali, G.D.; Teixeira, M.M.; Oliveira, S.C. Schistosoma mansoni antigens modulate experimental allergic asthma in a murine model: a major role for CD4+ CD25+ Foxp3+ T cells independent of interleukin-10. Infect. Immun., 2009, 77, 98-107.
18. Liu, P.; Li, J.; Yang, X.; Shen, Y.; Zhu, Y.; Wang, S.; Wu, Z.; Liu, X.; An, G.; Ji, W.; Gao, W. Helminth infection inhibits airway allergic reaction and dendritic cells are involved in the modulation process. Parasite Immunol., 2010, 32, 57-66.
19. Mo, H.M.; Lei, J.H.; Jiang, Z.W.; Wang, C.Z.; Cheng, Y.L.; Li, Y.L.; Liu, W.Q. Schistosoma japonicum infection modulates the development of allergen-induced airway inflammation in mice. Parasitol. Res., 2008, 1183-1189.
20. Hartmann, S.; Schnoeller, C.; Dahten, A.; Avagyan, A.; Rausch, S.; Lendner, M.; Bocian, C.; Pillai, S.; Loddenkemper, C.; Lucius, R.; Worm, M.; Hamelmann, E. Gastrointestinal nematode infection interferes with experimental allergic airway inflammation but not atopic dermatitis. Clin. Exp. Allergy, 2009, 39, 1585-1596.
21. Jones M. Understanding of the molecular mechanisms of allergy. Methods Mol. Med., 2008, 138, 1-15.
22. Abbas, A.K.; Murphy K.M.; Sher A. Functional diversity of helper T lymphocytes. Nature, 1996, 383, 787-793.
23. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol., 1999, 17, 255-281.
24. Soroosh P.; Doherty T.A. Th9 and allergic disease. Immunology, 2009, 127, 450-458.
25. Yssel, H.; Schneider, P.; Spits, H. Production of IL4 by human T cells and regulation of differentiation of T-cell subsets by IL4. Res. Immunol., 1993, 144, 610-616.
26. Tamachi, T.; Maezawa, Y.; Ikeda, K.; Kagami, S.; Hatano, M.; Seto, Y.; Suto, A.; Suzuki, K.; Watanabe, N.; Saito, Y.; Tokuhisa, T.; Iwamoto, I.; Nakajima, H. IL-25 enhances allergic airway inflammation by amplifying a TH2 cell-dependent pathway in mice. J. Allergy Clin. Immunol., 2006, 118, 606-614.
27. Wang, Y.H.; Angkasekwinai, P.; Lu, N.; Voo, K.S.; Arima, K.; Hanabuchi, S.; Hippe, A.; Corrigan, C.J.; Dong, C.; Homey, B.; Yao, Z.; Ying, S.; Huston, D.P.; Liu, Y.J. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J. Exp. Med., 2007, 204, 1837-1847.
28. Angkasekwinai, P.; Park, H.; Wang, Y.H.; Chang, S.H.; Corry, D.B.; Liu, Y.J.; Zhu, Z.; Dong, C. Interleukin 25 promotes the initiation of proallergic type 2 responses. J. Exp. Med., 2007, 204, 1509-1517.
29. Sharkhuu, T.; Matthaei, K.I.; Forbes, E.; Mahalingam, S.; Hogan, S.P.; Hansbro, P.M.; Foster, P.S. Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyperreactivity. Clin. Exp. Allergy, 2006, 36, 1575-1583.
30. Tamachi, T.; Maezawa, Y.; Ikeda, K.; Iwamoto, I.; Nakajima, H. Interleukin 25 in allergic airway inflammation. Int. Arch. Allergy Immunol., 2006, 140 Suppl 1, 59-62.
31. Allakhverdi, Z.; Smith, D.E.; Comeau, M.R.; Delespesse, G. Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J. Immunol., 2007; 179, 2051-2054.
32. Bach, J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med., 2002, 347, 911-920.
33. Elliott, D.E.; Summers, R.W.; Weinstock, J.V. Helminths as governors of immune-mediated inflammation. Int. J. Parasitol., 2007, 37, 457-464.
34. Bach J.F. Infections and autoimmune diseases. J. Autoimmun., 2005, 25(Suppl), 74-80.
35. Araujo, M.I.; Hoppe, B.S.; Medeiros, M. Jr.; Carvalho, E.M. Schistosoma mansoni infection modulates the immune response against allergic and auto-immune diseases. Mem. Inst. Oswaldo Cruz, 2004, 99, 27-32.
36. Wilson, M.S.; Maizels, R.M. Regulation of allergy and autoimmunity in helminth infection. Clin. Rev. Allergy Immunol., 2004, 26, 35-50.
37. La Flamme, A.C.; Ruddenklau, K.; Backstrom, B.T. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect. Immun., 2003, 71, 4996-5004.
38. Zaccone, P.; Fehervari, Z.; Jones, F.M.; Sidobre, S.; Kronenberg, M.; Dunne, D.W.; Cooke, A. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur. J. Immunol., 2003, 33, 1439-1449.
39. Hubner, M.P.; Stocker, J.T.; Mitre, E. Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells. Immunology, 2009, 127, 512-522.
40. Hansen, G.; Berry, G.; DeKruyff, R.H.; Umetsu, D.T. Allergenspecific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest., 1999, 103,175-183.
41. Abdulamir, A.S.; Hafidh, R.R.; Abubakar, F.; Abbas, K.A. Changing survival, memory cell compartment, and T-helper balance of lymphocytes between severe and mild asthma. BMC Immunol., 2008, 9, 73.
42. Nakagome, K.; Okunishi, K.; Imamura, M.; Harada, H.; Matsumoto, T.; Tanaka, R.; Miyazaki, J.; Yamamoto, K.; Dohi, M. IFN-gamma attenuates antigen-induced overall immune response in the airway as a Th1-type immune regulatory cytokine. J. Immunol., 2009, 183, 209-220.
43. Gariboldi, S.; Palazzo, M.; Zanobbio, L.; Dusio, G.F.; Mauro, V.; Solimene, U.; Cardani, D.; Mantovani, M.; Rumio, C. Low dose oral administration of cytokines for treatment of allergic asthma. Pulm. Pharmacol. Ther., 2009, 22 (6), 497-510.
44. Scholz, D.; Brandt-Hofflin, K.; Hahn, H.L. Effect of recombinant gamma interferon on allergic skin reaction and bronchoconstriction. Pneumologie, 1990, 44(Suppl 1), 431-432.
45. Garcia-Vega, Y.; Rodriguez-Perez, J.; Bermudez-Badell, C.; Blanco-Garces, E.; Valenzuela-Silva, C.; Lopez-Saura, P.; Bello-Rivero, I. Immunoglobulin E-dependent regulation of the CCR3 chemokine receptor by interferon-gamma in atopic asthmatics. Int. Arch. Allergy Immunol., 2009, 148, 219-227.
46. Fiorentino, D.F.; Bond, M.W.; Mosmann, T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med., 1989, 170, 2081-2095.
47. Akdis, C.A.; Blaser, K. Mechanisms of interleukin-10-mediated immune suppression. Immunology, 2001, 103,131-136.
48. Del Prete, G.; De Carli, M.; Almerigogna, F.; Giudizi, M.G.; Biagiotti, R.; Romagnani, S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) t cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol., 1993, 150, 353-360.
49. Sher, A.; Fiorentino, D.; Caspar, P.; Pearce, E.; Mosmann, T. Production of IL-10 by CD4+ T lymphocytes correlates with downregulation of Th1 cytokine synthesis in helminth infection. J. Immunol., 1991, 147, 2713-2716.
50. Royer, B.; Varadaradjalou, S.; Saas, P.; Gabiot, A.C.; Kantelip, B.; Feger F.; Guillosson, J.J.; Kantelip, J.P.; Arock, M. Autocrine regulation of cord blood-derived human mast cell activation by IL-10. J. Allergy Clin. Immunol., 2001, 108, 80-86.
51. Akdis, C.A.; Blesken, T.; Akdis, M.; Wuthrich, B.; Blaser, K. Role of interleukin 10 in specific immunotherapy. J. Clin. Invest., 1998, 102, 98-106.
52. Burastero, S.E.; Mistrello, G.; Falagiani, P.; Paolucci, C.; Breda, D.; Roncarolo, D.; Zanotta, S.; Monasterolo, G.; Rossi, R.E. Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production. Ann. Allergy Asthma Immunol., 2008, 100, 343-350.
53. Araújo, M.I.; de Jesus, A.R.; Bacellar, O.; Sabin, E.; Pearce, E.; Carvalho, E.M. Evidence of a T helper type 2 activation in human schistosomiasis. Eur. J. Immunol., 1996, 26, 1399-1403.
54. Cardoso, L.S.; Oliveira, S.C.; Pacifico, L.G.; Goes, A.M.; Oliveira, R.R.; Fonseca, C.T.; Carvalho, E.M.; Araújo, M.I. Schistosoma mansoni antigen-driven interleukin-10 production in infected asthmatic individuals. Mem. Inst. Oswaldo Cruz, 2006, 101 Suppl 1, 339-343.
55. Zouain, C.S.; Gustavson, S.; Oliveira, S.C.; Azevedo, V.; Alves, J.B.; Goes, A.M. The role of IL-10 and IgG1 in the protection and granulomatous response in Schistosoma mansoni P24-immunized mice. Vaccine., 2000, 19, 1218-1224.
56. Massague, J.; Andres, J.; Attisano, L.; Cheifetz, S.; Lopez-Casillas, F.; Ohtsuki, M.; Wrana, J.L. TGF-beta receptors. Mol. Reprod. Dev., 1992, 32, 99-104.
57. Sporn, M.B.; Roberts, A.B.; Wakefield, L.M.; Assoian, R.K. Transforming growth factor-beta: biological function and chemical structure. Science, 1986, 233, 532-534.
58. McCartney-Francis, N.L.; Wahl, S.M. Transforming growth factor beta: a matter of life and death. J. Leukoc. Biol., 1994, 55, 401-409.
59. Kehrl, J.H.; Wakefield, L.M.; Roberts, A.B.; Jakowlew, S.; Alvarez-Mon, M.; Derynck, R.; Sporn, M.B.; Fauci, A.S. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med., 1986, 163, 1037-1050.
60. Holgate, S.T. Epithelial damage and response. Clin. Exp. Allergy, 2000, 30(Suppl 1), 37-41.
61. Hansen, G.; McIntire, J.J.; Yeung, V.P.; Berry, G.; Thorbecke, G.J.; Chen, L.; DeKruyff, R.H.; Umetsu, D.T. CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergeninduced airway hyperreactivity and inflammation. J. Clin. Invest., 2000, 105, 61-70.
62. Veldhoen, M.; Hocking, R.J.; Atkins, C.J.; Locksley, R.M.; Stockinger, B. TGF beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity., 2006, 24, 179-189.
63. Read, S.; Powrie, F. CD4(+) regulatory T cells. Curr. Opin. Immunol., 2001, 13, 644-649.
64. Sakaguchi, S.; Sakaguchi, N.; Asano, M.; Itoh, M.; Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol., 1995, 155, 1151-1164.
65. Yssel, H.; Lecart, S.; Pene, J. Regulatory T cells and allergic asthma. Microbes Infect., 2001, 3, 899-904.
66. Weiner, H.L. Oral tolerance for the treatment of autoimmune diseases. Annu. Rev. Med., 1997, 48, 341-51.
67. Chen, Y.; Kuchroo, V.K.; Inobe, J.; Hafler, D.A.; Weiner, H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science, 1994, 265, 1237-1240.
68. Groux, H.; O'Garra, A.; Bigler, M.; Rouleau, M.; Antonenko, S.; de Vries, J.E.; Roncarolo, M.G. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature, 1997, 389, 737-742.
69. Cottrez, F.; Hurst, S.D.; Coffman, R.L.; Groux, H. T regulatory cells 1 inhibit a Th2-specific response in vivo. J. Immunol., 2000, 165,4848-4853.
70. Reinwald, S.; Wiethe, C.; Westendorf, A.M.; Breloer, M.; Probst-Kepper, M.; Fleischer, B.; Steinkasserer, A.; Buer, J.; Hansen, W. CD83 expression in CD4+ T cells modulates inflammation and autoimmunity. J. Immunol., 2008, 180, 5890-5897.
71. Brandenburg, S.; Takahashi, T.; de la Rosa, M.; Janke, M.; Karsten, G.; Muzzulini, T.; Orinska, Z.; Bulfone-Paus, S.; Scheffold, A. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells. Eur. J. Immunol., 2008, 38, 1643-1653.
72. Zaccone, P.; Burton, O.; Miller, N.; Jones, F.M.; Dunne, D.W.; Cooke, A. Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice. Eur. J. Immunol., 2009, 39, 1098-1107.
73. Curotto de Lafaille, M.A.; Lafaille, J.J. CD4(+) regulatory T cells in autoimmunity and allergy. Curr. Opin. Immunol., 2002, 14, 771-778.
74. Yang, J.; Zhao, J.; Yang, Y.; Zhang, L.; Yang, X.; Zhu, X.; Ji, M.; Sun, N.; Su, C. Schistosoma japonicum egg antigens stimulate CD4 CD25 T cells and modulate airway inflammation in a murine model of asthma. Immunology, 2007, 120, 8-18.
75. Umetsu, D.T.; Akbari, O.; Dekruyff, R.H. Regulatory T cells control the development of allergic disease and asthma. J. Allergy Clin. Immunol., 2003, 112, 480-487; quiz 8.
76. Curotto de Lafaille, M.A.; Kutchukhidze, N.; Shen, S.; Ding, Y.; Yee, H.; Lafaille, J.J. Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity, 2008, 29, 114-126.
77. Joetham, A.; Matsubara, S.; Okamoto, M.; Takeda, K.; Miyahara, N.; Dakhama, A.; Gelfand, E.W. Plasticity of regulatory T cells, subversion of suppressive function and conversion to enhancement of lung allergic responses. J. Immunol., 2008, 180, 7117-7124.
78. Mangan, N.E.; van Rooijen, N.; McKenzie, A.N.; Fallon, P.G. Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperresponsiveness. J. Immunol., 2006, 176, 138-147.
79. Jonuleit, H.; Schmitt, E.; Kakirman, H.; Stassen, M.; Knop, J.; Enk, A.H. Infectious tolerance, human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J. Exp. Med., 2002, 196, 255-260.
80. Dieckmann, D.; Bruett, C.H.; Ploettner, H.; Lutz, M.B.; Schuler, G. Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. J. Exp. Med., 2002, 196, 247-253.
81. Wilson, S.B.; Delovitch, T.L. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat. Rev. Immunol., 2003, 3, 211-222.
82. Godfrey, D.I.; Stankovic, S.; Baxter, A.G. Raising the NKT cell family. Nat. Immunol., 2010, 11, 197-206.
83. Lisbonne, M.; Leite-de-Moraes, M.C. Invariant Valpha14 NKT lymphocytes: a double-edged immuno-regulatory T cell population. Eur. Cytokine Netw., 2003, 14, 4-14.
84. Akbari, O.; Stock, P.; Meyer, E.; Kronenberg, M.; Sidobre, S.; Nakayama, T.; Taniguchi, M.; Grusby, M.J.; DeKruyff, R.H.; Umetsu, D.T. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med., 2003, 9, 582-588.
85. Bilenki, L.; Yang, J.; Fan, Y.; Wang, S.; Yang, X. Natural killer T cells contribute to airway eosinophilic inflammation induced by ragweed through enhanced IL-4 and eotaxin production. Eur. J. Immunol., 2004, 34, 345-354.
86. Kim, J.O.; Kim, D.H.; Chang, W.S.; Hong, C.; Park, S.H.; Kim, S.; Kang, C.Y. Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model. J. Allergy Clin. Immunol., 2004, 114, 1332-1338.
87. Meyer, E.H.; Goya, S.; Akbari, O.; Berry, G.J.; Savage, P.B.; Kronenberg, M.; Nakayama, T.; DeKruyff, R.H.; Umetsu, D.T. Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc. Natl. Acad. Sci., 2006, 103, 2782-2787.
88. Akbari O.; Faul J.L.; Hoyte E.G.; Berry G.J.; Wahlstrom, J.; Kronenberg, M.; DeKruyff, R.H.; Umetsu, D.T. CD4+ invariant Tcell-receptor+ natural killer T cells in bronchial asthma. N. Engl. J. Med., 2006, 354, 1117-1129.
89. Vijayanand, P.; Seumois, G.; Pickard, C.; Powell, R.M.; Angco, G.; Sammut, D.; Gadola, S.D.; Friedmann, P.S.; Djukanovic, R. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N. Engl. J. Med., 2007, 356, 1410-1422.
90. Bendelac, A.; Savage, P.B.; Teyton, L. The biology of NKT cells. Annu. Rev. Immunol., 2007, 25, 297-336.
91. Coquet, J.M.; Kyparissoudis, K.; Pellicci, D.G.; Besra, G.; Berzins, S.P.; Smyth, M.J.; Godfrey, D.I. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J. Immunol., 2007, 178, 2827-2834.
92. Harada, M.; Magara-Koyanagi, K.; Watarai, H.; Nagata, Y.; Ishii, Y.; Kojo, S.; Horiguchi, S.; Okamoto, Y.; Nakayama, T.; Suzuki, N.; Yeh, W.C.; Akira, S.; Kitamura, H.; Ohara, O.; Seino, K.; Taniguchi, M. IL-21-induced Bepsilon cell apoptosis mediated by natural killer T cells suppresses IgE responses. J. Exp. Med,. 2006, 203, 2929-2937.
93. Spolski, R.; Leonard, W.J. The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr. Opin. Immunol., 2008, 20, 295-301.
94. Shang, X.Z.; Ma, K.Y.; Radewonuk, J.; Li, J.; Song, X.Y.; Griswold, D.E.; Emmell, E.; Li, L. IgE isotype switch and IgE production are enhanced in IL-21-deficient but not IFN-gammadeficient mice in a Th2-biased response. Cell. Immunol., 2006, 241, 66-74.
95. Hiromura, Y.; Kishida, T.; Nakano, H.; Hama, T.; Imanishi, J.; Hisa, Y.; Mazda, O. IL-21 administration into the nostril alleviates murine allergic rhinitis. J. Immunol., 2007, 179, 7157-7165.
96. Kishida, T.; Hiromura, Y.; Shin-Ya, M.; Asada, H.; Kuriyama, H.; Sugai, M.; Shimizu, A.; Yokota, Y.; Hama, T.; Imanishi, J.; Hisa, Y.; Mazda, O. IL-21 induces inhibitor of differentiation 2 and leads to complete abrogation of anaphylaxis in mice. J. Immunol., 2007, 179, 8554-8561.
97. Hagel, I.; Lynch, N.R.; Perez, M.; Di Prisco, M.C.; Lopez, R.; Rojas, E. Modulation of the allergic reactivity of slum children by helminthic infection. Parasite Immunol., 1993, 15, 311-315.
98. Lynch, N.R.; Hagel, I.; Perez, M.; Di Prisco, M.C.; Lopez, R.; Alvarez, N. Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. J. Allergy Clin. Immunol., 1993, 92, 404-411.
99. Cooper, P.J.; Chico, M.E.; Rodrigues, L.C.; Ordonez, M.; Strachan, D.; Griffin, G.E.; Nutman, T.B. Reduced risk of atopy among school-age children infected with geohelminth parasites in a rural area of the tropics. J. Allergy Clin. Immunol., 2003, 111, 995-1000.
100. Hussain, R.; Poindexter, R.W.; Ottesen, E.A. Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. J. Immunol., 1992, 148, 2731-2737.
101. Letterio, J.J.; Roberts, A.B. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol., 1998, 16, 137-161.
102. Scrivener, S.; Yemaneberhan, H.; Zebenigus, M.; Tilahun, D.; Girma, S.; Ali, S.; McElroy, P.; Custovic, A.; Woodcock, A.; Pritchard, D.; Venn, A.; Britton, J. Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study. Lancet., 2001, 358, 1493-1499.
103. Araújo, M.I.; Lopes, A.A.; Medeiros, M.; Cruz, A.A.; Sousa-Atta, L.; Sole, D.; Carvalho, E.M. Inverse association between skin response to aeroallergens and Schistosoma mansoni infection. Int. Arch. Allergy Immunol., 2000, 123, 145-148.
104. Ebner, C.; Siemann, U.; Bohle, B.; Willheim, M.; Wiedermann, U.; Schenk, S.; Klotz, F.; Ebner, H.; Kraft, D.; Scheiner, O. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin. Exp. Allergy, 1997, 27, 1007-1015.
105. Platts-Mills, T.; Vaughan, J.; Squillace, S.; Woodfolk, J.; Sporik, R. Sensitisation; asthma, and a modified Th2 response in children exposed to cat allergen, a population-based cross-sectional study. Lancet, 2001, 357, 752-756.
106. Medeiros, M. Jr.; Figueiredo, J.P.; Almeida, M.C.; Matos, M.A.; Araújo, M.I.; Cruz, A.A.; Atta, A.M.; Rego, M.A.; de Jesus, A.R.; Taketomi, E.A.; Carvalho, E.M. Schistosoma mansoni infection is associated with a reduced course of asthma. J. Allergy Clin. Immunol., 2003, 111, 947-951.
107. Royer, B.; Varadaradjalou, S.; Saas, P.; Guillosson, J.J.; Kantelip, J.P.; Arock, M. Inhibition of IgE-induced activation of human mast cells by IL-10. Clin. Exp. Allergy, 2001, 31, 694-704.
108. Bretscher, P.; Cohn, M. A theory of self-nonself discrimination. Science, 1970, 169, 1042-1049.
109. Walunas, T.L.; Lenschow, D.J.; Bakker, C.Y.; Linsley, P.S.; Freeman, G.J.; Green, J.M.; Thompson, C.B.; Bluestone, J.A. CTLA-4 can function as a negative regulator of T cell activation. Immunity., 1994, 1, 405-413.
110. Tsuyuki, S.; Tsuyuki, J.; Einsle, K.; Kopf, M.; Coyle, A.J. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J. Exp. Med., 1997, 185, 1671-1679.
111. Mandelbrot, D.A.; McAdam, A.J.; Sharpe, A.H. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J. Exp. Med., 1999, 189, 435-440.
112. Cooper, P.J.; Chico, M.E.; Sandoval, C.; Nutman, T.B. Atopic phenotype is an important determinant of immunoglobulin Emediated inflammation and expression of T helper cell type 2 cytokines to ascaris antigens in children exposed to ascariasis. J. Infect. Dis., 2004, 190, 1338-1346.
113. Ponte, E.V.; Lima, F.; Araújo, M.I.; Oliveira, R.R.; Cardoso, L.S.; Cruz, A.A. Skin test reactivity and Der p-induced interleukin 10 production in patients with asthma or rhinitis infected with Ascaris. Ann. Allergy. Asthma Immunol., 2006, 96, 713-718.
114. Bager, P.; Arnved, J.; Ronborg, S.; Wohlfahrt, J.; Poulsen, L.K.; Westergaard, T.; Petersen, H.W.; Kristensen, B.; Thamsborg, S.; Roepstorff, A.; Kapel, C.; Melbye, M. Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial. J. Allergy Clin. Immunol., 2010, 125, 123-30 e1-3.
115. Flohr, C.; Tuyen, L.N.; Quinnell, R.J.; Lewis, S.; Minh, T.T.; Campbell, J.; Simmons, C.; Telford, G.; Brown, A.; Hien, T.T.; Farrar, J.; Williams, H.; Pritchard, D.I.; Britton, J. Reduced helminth burden increases allergen skin sensitization but not clinical allergy, a randomized, double-blind, placebo-controlled trial in Vietnam. Clin. Exp. Allergy, 2009, 40, 131-142.
116. Jeffs, S.A.; Hagan, P.; Allen, R.; Correa-Oliveira, R.; Smithers, S.R.; Simpson, A.J. Molecular cloning and characterization of the 22-kilodalton adult Schistosoma mansoni antigen recognized by antibodies from mice protectively vaccinated with isolated tegumental surface membranes. Mol. Biochem. Parasitol., 1991, 46, 159-167.
117. Cardoso, F.C.; Pacifico, R.N.; Mortara, R.A.; Oliveira, S.C. Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies. Clin. Exp. Immunol., 2006, 144, 382-391.
118. Hirsch, C.; Goes, A.M. Characterization of fractionated Schistosoma mansoni soluble adult worm antigens that elicit human cell proliferation and granuloma formation in vitro. Parasitology, 1996, 112 (Pt 6), 529-535.
119. Oliveira, D.M.; Gustavson, S.; Silva-Teixeira, D.N.; Goes, A.M. Nitric oxide and IL-10 production induced by PIII-a fraction of Schistosoma mansoni adult worm antigenic preparation-associated with downregulation of in vitro granuloma formation. Hum. Immunol., 1999, 60, 305-311.
120. Zouain, C.S.; Gustavson, S.; Silva-Teixeira, D.N.; Contigli, C.; Rodrigues, V. Jr.; Leite, M.F.; Goes, A.M. Human immune response in schistosomiasis: the role of P24 in the modulation of cellular reactivity to Schistosoma mansoni antigens. Hum. Immunol., 2002, 63, 647-656.
121. Chung, K.F. Anti-IgE monoclonal antibody, omalizumab, a new treatment for allergic asthma. Expert. Opin. Pharmacother., 2004, 5, 439-446.
122. Noga, O.; Hanf, G.; Kunkel, G. Immunological and clinical changes in allergic asthmatics following treatment with omalizumab. Int. Arch. Allergy Immunol., 2003, 131, 46-52.
123. Akdis, C.A.; Blaser, K. Immunologic mechanisms of allergenspecific immunotherapy. Adv. Exp. Med. Biol.; 2001, 495, 247-259.
124. Akdis, C.A., Blaser, K. Role of IL-10 in allergen-specific immunotherapy and normal response to allergens. Microbes Infect., 2001, 3, 891-898.